Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,064,766
+$20,051,286 QoQ
Shares Held
79,736
+135045.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#605
of 4,153 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 53%
Shared 47%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Dec 31, 2025CallValue
$1,576,581
CallShares
6,900
PutValue
$3,038,917
PutShares
13,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LMR Partners LLP holds $144,798,606 across 13 Drug Manufacturers - General names. ABBV ranks #3 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
980,479 | $51,396,709 | |
| 2 | NVS |
Novartis AG
|
153,726 | $24,091,938 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
79,736 | $20,064,766 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
330,151 | $19,023,300 | |
| 5 | PFE |
Pfizer Inc
|
260,990 | $6,284,639 | |
| 6 | MRK |
Merck & Co., Inc.
|
44,030 | $5,657,855 | |
| 7 | OGN |
Organon & Co.
|
396,842 | $5,373,240 | |
| 8 | LLY |
ELI LILLY & Co
|
3,390 | $4,066,066 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,064,766 | 79,736 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $13,480 | 59 | Shares | Other | 2026-02-17 | |
| 2025-12-31 | $3,038,917 | 13,300 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $1,576,581 | 6,900 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $463 | 2 | Shares | Other | 2025-11-14 | |
| 2025-09-30 | $3,079,482 | 13,300 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $1,597,626 | 6,900 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $445,488 | 2,400 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $1,132,467 | 6,101 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $3,304,036 | 17,800 | Put | Sole | 2025-08-14 | |
| 2025-03-31 | $1,952,306 | 9,318 | Shares | Other | 2025-05-15 | |
| 2025-03-31 | $4,986,576 | 23,800 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $4,253,256 | 20,300 | Call | Sole | 2025-05-15 | |
| 2024-03-31 | $4,661,760 | 25,600 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $5,208,060 | 28,600 | Put | Sole | 2024-05-15 | |
| 2023-12-31 | $3,967,232 | 25,600 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $4,432,142 | 28,600 | Put | Sole | 2024-02-14 | |
| 2023-06-30 | $2,695,543 | 20,007 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $440,611 | 3,283 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,821,495 | 24,951 | Shares | Sole | 2022-08-15 | |
| 2021-09-30 | $2,383,603 | 22,097 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,227,438 | 10,897 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,093,407 | 19,344 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $896,095 | 8,363 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,138,247 | 24,412 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $1,314,582 | 17,254 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||